Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-17-002735

Options or other derivatives

  • Chief Medical Officer acquired 545,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Benaim Ely · Chief Medical Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-01-20 Grant or award : show line 1 in the form Stock Option (right to buy) +450,000 $0.18 2027-01-20 450,000 450,000 D
2017-01-20 Grant or award : show line 2 in the form Restricted Stock Units +95,000 95,000 95,000 D
Loading xslF345X03/form4.xml…